REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & NephewAnnouncement

Yesterday 09:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260402:nRSB2522Za&default-theme=true

RNS Number : 2522Z  Smith & Nephew Plc  02 April 2026

SMITH & NEPHEW PLC

 

2 April 2026

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

This announcement is made in accordance with the UK Market Abuse Regulation
(Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the
European Union (Withdrawal) Act 2018).

 

1.   AWARDS MADE UNDER THE SMITH & NEPHEW PLC DEFERRED SHARE BONUS PLAN

 

On 1 April 2026, the following awards of US$0.20 ordinary shares (the
"Shares") in Smith & Nephew plc (the "Company") were granted under the
Deferred Share Bonus Plan. The number of Shares awarded has been calculated
using a market price of £12.744 per Share, being the average of the quoted
closing prices of a Share for the ten (10) dealing days immediately following
the announcement of the Company's full year 2025 results on 2 March 2026.

 

A portion (50%) of the annual bonus earned by the following Executive
Directors for performance during the year to 31 December 2025 has been
deferred into share awards. The awards will normally vest on 15 March 2029.
The Executive Directors will receive an additional number of shares equivalent
to the amount of dividend payable per vested share during the relevant vesting
period.

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Ordinary Shares of USD 0.20 each

 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Awards granted on 1 April 2026 under the Deferred Share Bonus Plan.
 Date of Transaction                                          2026 - 04 - 01
 Place of Transaction                                         Grant took place outside a trading venue

 

 Name                        Status    Price (s)  Volume(s)  Aggregated information

 (Position)
 Deepak Nath                 Director  £12.744    83,494     N/A Single Transaction

 (Chief Executive Officer)
 John Rogers                 Director  £12.744    48,071     N/A Single Transaction

 (Chief Financial Officer)

 

 

2.   PERFORMANCE SHARE AWARDS MADE UNDER THE SMITH & NEPHEW PLC GLOBAL
SHARE PLAN 2020

 

On 1 April 2026, the following awards of US$0.20 ordinary shares (the
"Shares") in Smith & Nephew plc (the "Company") were granted under the
Global Share Plan 2020. The number of Shares awarded has been calculated using
a market price of £12.744 per Share, being the average of the quoted closing
prices of a Share for the ten (10) dealing days immediately following the
announcement of the Company's full year 2025 results on 2 March 2026.

 

Awards will vest on 15 March 2029, subject to the achievement of performance
conditions which are measured over the period 1 January 2026 to 31 December
2028.

 

The number of shares subject to the above awards are shown at maximum vesting.
Should less than maximum vesting be achieved, participants will receive a
reduced number of shares in accordance with actual performance. Participants
will receive an additional number of shares equivalent to the amount of
dividend payable per vested share during the relevant performance period.

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Ordinary Shares of USD 0.20 each

 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Awards granted on 1 April 2026 under the Global Share Plan 2020.
 Date of Transaction                                          2026 - 04 - 01
 Place of Transaction                                         Grant took place outside a trading venue

 

 

 Name                                                                 Status  Price (£)   Volume   Aggregated information

 (Position)
 Deepak Nath                                                          PDMR    £12.744     285,473  N/A Single Transaction

 (Chief Executive Officer)
 John Rogers                                                          PDMR    £12.744     154,229  N/A Single Transaction

 (Chief Financial Officer)
 Helen Barraclough                                                    PDMR    £12.744     55,550   N/A Single Transaction

 (Group General Counsel & Company Secretary)
 Paul Connolly                                                        PDMR    £12.744     51,531   N/A Single Transaction

 (President, Global Operations)
 Ajay Dhankhar (Chief Strategy & Corporate Development Officer)       PDMR    £12.744     110,751  N/A Single Transaction
 Craig Gaffin                                                         PDMR    £12.744     91,258   N/A Single Transaction

 (President Orthopaedics)
 Rohit Kashyap                                                        PDMR    £12.744     112,073  N/A Single Transaction

 (President AWM & Global Commercial Operations)
 Mizanu Kebede                                                        PDMR    £12.744     53,921   N/A Single Transaction

 (Chief Quality & Regulatory Affairs Officer)
 Elga Lohler                                                          PDMR    £12.744     67,747   N/A Single Transaction

 (Chief HR Officer)
 Vasant Padmanabhan                                                   PDMR    £12.744     71,044   N/A Single Transaction

 (President Research & Development, ENT & Emerging Markets)
 Alison Parkes                                                        PDMR    £12.744     19,679   N/A Single Transaction

 (Chief Compliance Officer)
 Scott Schaffner                                                      PDMR    £12.744     107,053  N/A Single Transaction

 (Global President Sports Medicine)

 

 

 

 

 

 

 

3.   AWARDS MADE UNDER THE SMITH & NEPHEW PLC RESTRICTED SHARE PLAN 2024

 

On 1 April 2026, the following awards of US$0.20 ordinary shares (the
"Shares") in Smith & Nephew plc (the "Company") were granted under the
Restricted Share Plan 2024. The number of Shares awarded has been calculated
using a market price of £12.744 per Share, being the average of the quoted
closing prices of a Share for the ten (10) dealing days immediately following
the announcement of the Company's full year 2025 results on 2 March 2026.

 

The awards will normally vest in equal annual tranches over three years
following the award date. In addition, Deepak Nath's and John Rogers' awards
are subject to a reasonable judgement underpin. If the Remuneration Committee
is not satisfied that the underpin has been met, the Committee may scale back
the vesting (including to zero). In assessing the underpin, the Committee will
consider a review of overall financial performance over the vesting period,
whether there have been any sanctions or fines issued by a regulatory
authority, whether there have been any material environmental, social or
governance issues, whether a major safety incident has occurred and whether
there has been material damage to the reputation of the Company.

 

Participants will receive an additional number of shares equivalent to the
amount of dividend payable per vested share during the relevant vesting
period.

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Ordinary Shares of USD 0.20 each

 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Awards granted on 1 April 2026 under the Restricted Share Plan 2024.
 Date of Transaction                                          2026 - 04 - 01
 Place of Transaction                                         Grant took place outside a trading venue

 

 Name                                                                 Status  Price (£)   Volume   Aggregated information

 (Position)
 Deepak Nath                                                          PDMR    £12.744     118,947  N/A Single Transaction

 (Chief Executive Officer)
 John Rogers                                                          PDMR    £12.744     64,262   N/A Single Transaction

 (Chief Financial Officer)
 Helen Barraclough                                                    PDMR    £12.744     21,927   N/A Single Transaction

 (Group General Counsel & Company Secretary)
 Paul Connolly                                                        PDMR    £12.744     26,443   N/A Single Transaction

 (President, Global Operations)
 Ajay Dhankhar (Chief Strategy & Corporate Development Officer)       PDMR    £12.744     42,009   N/A Single Transaction
 Craig Gaffin                                                         PDMR    £12.744     24,230   N/A Single Transaction

 (President Orthopaedics)
 Rohit Kashyap                                                        PDMR    £12.744     55,263   N/A Single Transaction

 (President AWM & Global Commercial Operations)
 Mizanu Kebede                                                        PDMR    £12.744     21,284   N/A Single Transaction

 (Chief Quality & Regulatory Affairs Officer)
 Elga Lohler                                                          PDMR    £12.744     34,764   N/A Single Transaction

 (Chief HR Officer)
 Vasant Padmanabhan                                                   PDMR    £12.744     28,043   N/A Single Transaction

 (President Research & Development, ENT & Emerging Markets)
 Alison Parkes                                                        PDMR    £12.744     7,379    N/A Single Transaction

 (Chief Compliance Officer)
 Scott Schaffner                                                      PDMR    £12.744     64,970   N/A Single Transaction

 (President Sports Medicine)

 

 

Philip Horner

Deputy Company Secretary

Smith & Nephew plc

 

Tel:  +44 (0)1923 477100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFIFVTSSIFIIR



            Copyright 2019 Regulatory News Service, all rights reserved